ClinicalTrials.gov record

Completed Phase 2Phase 3 Interventional Accepts healthy volunteers Results available

Botswana TDF/FTC Oral HIV Prophylaxis Trial

ClinicalTrials.gov ID: NCT00448669

Public ClinicalTrials.gov record NCT00448669. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jul 24, 2026, 5:58 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Study of the Safety and Efficacy of Daily Oral Antiretroviral Use for the Prevention of HIV Infection in Heterosexually Active Young Adults in Botswana

Study identification

NCT ID: NCT00448669
Recruitment status: Completed
Study type: Interventional
Phase: Phase 2, Phase 3
Lead sponsor: Centers for Disease Control and Prevention; Federal
Enrollment: 1,219 participants

Conditions and interventions

Conditions

HIV Infections

Interventions

Tenofovir Disoproxil Fumarate 300 mg + Emtricitabine 200 mg Drug
Placebo Oral Tablet Drug

Drug

Eligibility (public fields only)

Age range: 18 Years to 39 Years
Sex: All
Healthy volunteers: Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Feb 28, 2007
Primary completion: Feb 28, 2011
Completion: Feb 28, 2011
Last update posted: Feb 4, 2020

2007 – 2011

United States locations

U.S. sites: 1
U.S. states: 1
U.S. cities: 1

Facility	City	State	ZIP	Site status
Centers for Disease Control and Prevention	Atlanta	Georgia	30333	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00448669, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Feb 4, 2020 · Synced Jul 24, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00448669 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →